Hubungan Usia dan Jenis Kelamin terhadap Kematian Covid-19 di Kota Depok
The Relationship Between Age and Sex with Mortality of COVID-19 in Depok City
Abstract
Latar Belakang: Pandemi COVID-19, menyebar dengan cepat ke berbagai negara dan menyebabkan prevalensi, mortality rate dan case fatality rate terus meningkat secara signifikan. Kematian kasus positif COVID-19 terus meningkat di Indonesia khususnya di Kota Depok, dan hanya sedikit bukti yang tersedia yang menyoroti perspektif usia dan jenis kelamin dari penyakit ini.
Tujuan: Untuk mempelajari hubungan antara jenis kelamin dan usia pada pasien meninggal di antara kasus positif COVID-19.
Metode: Penelitian ini menggunakan desain case control. Populasi penelitian adalah pasien COVID-19 yang terdata pada Pusat Informasi Covid-19 Depok (PICODEP) dengan sampel adalah 87 pasien. Rasio perbandingan kasus dan kontrol adalah 1:4. Sehingga total sampel yaitu 435 pasien. Data yang dikumpulkan berupa data sekunder yaitu data surveilans pasien konfirmasi Covid-19 di Kota Depok periode bulan Juni – September 2021. Peneliti menggunakan uji chi square untuk melihat hubungan antara usia dan jenis kelamin terhadap kematian COVID-19
Hasil : Pada variabel jenis kelamin dipeloreh nilai p-value 0,046 artinya p < α (0,05) berarti ada hubungan antara jenis kelamin laki – laki dengan kejadian kematian pada pasien COVID-19. Dari analisis didapatkan nilai OR = 1,663 yang menunjukkan bahwa pada pasien covid-19 laki – laki berisiko 1,663 kali untuk mengalami kejadian kematian pada pasien COVID-19 dibandingkan perempuan. Selanjutnya, pada variabel usia menunjukkan ada hubungan antara kelompok usia manula dengan kejadian kematian pada pasien COVID-19 Covid-19 p-value 0,007 dengan kelompok usia manula berisiko 14,4 kali lebih tinggi untuk mengalami kejadian kematian pada pasien COVID-19 Covid-19 dibandingkan kelompok usia balita (OR: 14,400; 95% CI: 1,640 – 126,443 nilai p=0.007).
Kesimpulan: Terdapat hubungan antara usia dan jenis kelamin terhadap kematian COVID-19
References
Carenzo L, Elli D, Mainetti M, et al. 2020. A dedicated multidisciplinary safety briefing for the COVID-19 critical care. Intensive Crit Care Nurs. 60:102882. doi: 10.1016/j.iccn.2020.102882.
Chen N S, Zhou M, Dong X et al. 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395(10223):507–513
Triggle C.R., Bansal D., Ding H., Islam M.M., Farag E.A.B.A., Hadi H.A and Sultan A.A. 2021. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Frointiers in Immunology. doi: https://doi.org/10.3389/fimmu.2021.631139
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. Doi. https://doi.org/10.1016/S0140-6736(20)30183-5
Ciotti M, Ciccozzi M, Terrinoni A, Jiang W.C, Wang C.B, Bernardini S. 2020. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 57(6):365-388. doi: 10.1080/10408363.2020.1783198.
Lenti, M.V., Aronico, N., Pellegrino, I. et al. 2020. Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19. Sci Rep. https://doi.org/10.1038/s41598-020-77945-8
Karlinsky A and Kobak D. 2021. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. eLife. doi: 10.7554/eLife.69336
Dingtao H, Xiaoqi L, Nana M, Zhen L, • Ying T, Yanfeng Z, Fang Wang. 2021. Influence of age and sex on the epidemic of COVID-19: Evidence from 177 countries and territories—an exploratory, ecological study. Wien Klin Wochenschr. 133:321–330 https://doi.org/10.1007/s00508-021-01816-z
Sarkar A and Chouhan P. 2020. COVID-19: District level vulnerability assessment in India. Clinical Epidemiology and Global Health. doi: https://doi.org/10.1016/j.cegh.2020.08.017
Kushwaha A, Khanna P, Rajagopal V, Kiran T. 2021. Biological attributes of age and sex variations in Indian COVID-19 cases: A retrospective data analysis. Clinical Epidemiology and Global Health, doi: https://doi.org/10.1016/j.cegh.2021.100788.
Simon A K, Hollander G A and Mc.Michael A. 2015. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 282(1821):2014308
Pijls B.G, Jolani S, Atherley A, Derckx R.T, et al. 2020. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. http://dx.doi.org/10.1136/bmjopen-2020-044640
Liu R, Han H, Liu F et al. 2020. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta 505:172– 175. doi: https://doi.org/10.1016/j.cca.2020.03.009.
Rizzo P., Sega F.V.D., Fortini F., Marracino L., Rapezzi C and Ferrari R. 2020. COVID-19 in the heart and the lungs: could we “Notch†the inflammatory storm?. Basic Res Cardiol. doi: https://doi.org/10.1007/s00395-020-0791-5
Laia C.C, Liu Y.H, Wang C.Y et al. 2020. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Journal of Microbiology, Immunology and Infection. 53(3);404-412.
Zhou F, Yu T, Du R, et al. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study. Lancet. 20(30): 30566-3
Ruan Q, Yang K, Wang W et al. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 36(20):30566-3.
Sohrabi C, Alsafi Z, O'Neil N, et al. 2020. World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). Int J Surg. doi: 10.1016/j.ijsu.2020.03.036
Opal S. M, Timothy D. Girard, E. Wesley Ely, The Immunopathogenesis of Sepsis in Elderly Patients, Clinical Infectious Diseases, 41;S504–S512, doi: https://doi.org/10.1086/432007
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
